Page last updated: 2024-08-22

angiotensin ii and Graft Occlusion, Vascular

angiotensin ii has been researched along with Graft Occlusion, Vascular in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (11.11)	18.7374
1990's	2 (22.22)	18.2507
2000's	5 (55.56)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (11.11)	2.80

Authors

Authors	Studies
Badran, A; Baydoun, E; Bitto, A; Eid, AH; El-Yazbi, AF; Fardoun, MM; Mesmar, J; Nasser, SA	1
Takai, S	1
Miyazaki, M; Takai, S	2
Buikema, H; de Smet, BJ; Groenewegen, HC; Roks, AJ; van der Harst, P; van Gilst, WH; Zijlstra, F	1
Barber, L; Dalen, H; Davies, MG; Fulton, GJ; Hagen, PO; Svendsen, E	1
Borland, JA; Catravas, JD; Chester, AH; Crabbe, S; Parkerson, JB; Yacoub, MH	1
Achard, JM; Aldigier, JC; Fournier, A; Leborgne, L; Tribouilloy, C	1
Guidi, E	1

Reviews

5 review(s) available for angiotensin ii and Graft Occlusion, Vascular

Article	Year
Reactive Oxygen Species: Modulators of Phenotypic Switch of Vascular Smooth Muscle Cells. International journal of molecular sciences, 2020, Nov-20, Volume: 21, Issue:22 Topics: Angiotensin II; Antioxidants; Atherosclerosis; Biomarkers; Cardiovascular Agents; Cell Cycle Proteins; Cell Movement; Cell Proliferation; Fibroblast Growth Factors; Gene Expression Regulation; Graft Occlusion, Vascular; Humans; Hypertension; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADPH Oxidases; Oxidative Stress; Phenotype; Reactive Oxygen Species; Signal Transduction	2020
[Role of chymase in vascular diseases and the efficacy of chymase inhibitor]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2003, Volume: 122, Issue:2 Topics: Angioplasty, Balloon, Coronary; Angiotensin II; Animals; Blood Pressure; Chymases; Coronary Restenosis; Drug Design; Graft Occlusion, Vascular; Humans; Mast Cells; Serine Endopeptidases; Serine Proteinase Inhibitors; Vascular Diseases	2003
Application of a chymase inhibitor, NK3201, for prevention of vascular proliferation. Cardiovascular drug reviews, 2003,Fall, Volume: 21, Issue:3 Topics: Acetamides; Angioplasty, Balloon; Angiotensin II; Animals; Cell Division; Chymases; Endothelium, Vascular; Graft Occlusion, Vascular; Humans; Hypertension; Protease Inhibitors; Pyrimidines; Serine Endopeptidases; Vascular Diseases	2003
A novel therapeutic strategy against vascular disorders with chymase inhibitor. Current vascular pharmacology, 2003, Volume: 1, Issue:2 Topics: Angioplasty, Balloon; Angiotensin II; Animals; Blood Vessels; Chymases; Enzyme Inhibitors; Graft Occlusion, Vascular; Humans; Hypertension; Serine Endopeptidases; Vascular Diseases	2003
Hypertension and the kidney: lessons learned from transplantation. Journal of clinical hypertension, 1987, Volume: 3, Issue:3 Topics: Angiotensin II; Animals; Disease Models, Animal; Graft Occlusion, Vascular; Graft Rejection; Humans; Hypertension; Hypertension, Renovascular; Kidney; Kidney Transplantation; Postoperative Complications; Rats; Steroids	1987

Other Studies

4 other study(ies) available for angiotensin ii and Graft Occlusion, Vascular

Article	Year
Rosuvastatin attenuates angiotensin II-induced neointimal formation after stent implantation in the rat. Coronary artery disease, 2008, Volume: 19, Issue:1 Topics: Angiotensin II; Animals; Fluorobenzenes; Graft Occlusion, Vascular; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperplasia; Male; Pyrimidines; Random Allocation; Rats; Rats, Wistar; Rosuvastatin Calcium; Stents; Sulfonamides; Tunica Intima	2008
Characterisation of angiotensin II receptor mediated responses and inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor, L158,809. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 1996, Volume: 12, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Endothelium, Vascular; Graft Occlusion, Vascular; Hyperplasia; Imidazoles; Jugular Veins; Microscopy, Electron, Scanning; Muscle Contraction; Muscle, Smooth, Vascular; Rabbits; Receptors, Angiotensin; Tetrazoles; Tunica Intima	1996
Differential action of angiotensin II and activity of angiotensin-converting enzyme in human bypass grafts. The Journal of thoracic and cardiovascular surgery, 1998, Volume: 116, Issue:2 Topics: Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Coronary Artery Bypass; Female; Graft Occlusion, Vascular; Humans; Imidazoles; In Vitro Techniques; Losartan; Male; Middle Aged; Nitric Oxide Synthase; Peptidyl-Dipeptidase A; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Saphenous Vein; Thoracic Arteries; Vasoconstriction; Vasoconstrictor Agents	1998
Restenotic process and DD genotype after angiotensin-converting enzyme inhibitor treatment. Lancet (London, England), 2001, Sep-01, Volume: 358, Issue:9283 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Genotype; Graft Occlusion, Vascular; Humans; Isoquinolines; Peptidyl-Dipeptidase A; Quinapril; Tetrahydroisoquinolines	2001